Envista Holdings (NVST) Retained Earnings (2018 - 2026)
Envista Holdings (NVST) posted Retained Earnings of $3.9 billion for Q3 2026, little changed on a QoQ basis from $3.9 billion in Q2 2026, and up 1.19% year-over-year from $3.9 billion in Q3 2025.
Analysis
Envista Holdings (NVST) Retained Earnings (2018 - 2026) Analysis & Trends
Envista Holdings has reported Retained Earnings for 9 years, with the latest figure at $3.9 billion in Q3 2026.
- On a quarterly basis, Retained Earnings rose 1.19% year-over-year to $3.9 billion in Q3 2026; TTM through Jul 2026 was $3.9 billion, a 1.19% increase from a year earlier, with the FY2025 full-year figure at $3.9 billion, up 1.05% from the prior year.
- Retained Earnings was $3.9 billion for Q3 2026 at Envista Holdings, roughly flat from $3.9 billion in the prior quarter.
- The five-year high for Retained Earnings was $3.9 billion in Q3 2026, with the low at $3.7 billion in Q2 2022.
- Average Retained Earnings over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings dropped 0.9% in 2022, then climbed 2.35% in 2025.
- Over 5 years, Retained Earnings stood at $3.7 billion in 2022, then increased by 1.6% to $3.8 billion in 2023, then rose by 2.23% to $3.8 billion in 2024, then advanced by 1.05% to $3.9 billion in 2025, then gained by 0.61% to $3.9 billion in 2026.
- The last three Retained Earnings figures came in at $3.9 billion (Q3 2026), $3.9 billion (Q2 2026), and $3.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 2.60 Bn |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 3.91 Bn |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 6.62 Bn |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | -134.62 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | -23.32 Mn |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -138.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 3.91 Bn |
| Apr 3, 2026 | 3.90 Bn |
| Dec 31, 2025 | 3.88 Bn |
| Sep 26, 2025 | 3.87 Bn |
| Jun 27, 2025 | 3.86 Bn |
| Mar 28, 2025 | 3.85 Bn |
| Dec 31, 2024 | 3.84 Bn |
| Sep 27, 2024 | 3.78 Bn |
| Jun 28, 2024 | 3.77 Bn |
| Mar 29, 2024 | 3.77 Bn |
| Dec 31, 2023 | 3.76 Bn |
| Sep 29, 2023 | 3.75 Bn |
| Jun 30, 2023 | 3.72 Bn |
| Mar 31, 2023 | 3.71 Bn |
| Dec 31, 2022 | 3.70 Bn |
| Sep 30, 2022 | 3.69 Bn |
| Jul 1, 2022 | 3.68 Bn |
| Apr 1, 2022 | 3.67 Bn |
| Dec 31, 2021 | 3.73 Bn |
| Oct 1, 2021 | 3.72 Bn |